Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-542-8 | CAS number: 108-01-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not reported, published in 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: no data on GLP or OECD compliance. Acceptable, well documented publication which meets basic scientific principles.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- not reported, published 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: no data on GLP or OECD compliance. Acceptable, well ducumented publication which meets basic scientific principles.
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: OECD 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague-Dawley, Inc., Indianapolis, IN.
- Age at study initiation: 67-79 days old on arrival
- Weight at study initiation: not reported
- Fasting period before study: no
- Housing: in stainless-steel wire-meshcages
- Diet (e.g. ad libitum): ad libitum except during exposure
- Water (e.g. ad libitum): ad libitum except during exposure
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not reported
- Humidity (%): not reported
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light):12/12 - Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Liquid DMEA was metered from a piston pump into a heated glass maintained at the lowest temperature to vaporize the liquid. The resultant vapor was carried into the exposure chamber by a countercurrent flow of conditioned air through the evaporator. Exposure was conducted in 4320-litre stainless-steel and glass chambers at an airflow of 1000 L/min. - Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: no data
- Proof of pregnancy: [vaginal plug ] referred to as [day 0] of pregnancy
- After successful mating each pregnant female was caged (how): singly - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Chamber atmosphere was analyzed for DMEA concentrations once every 32 min during each 6-h exposure, using a Perkin-Elmer 3920B gas chromatograph equipped with a flame ionization detector. Nominal concentrations weere calculated daily based on the amount of DMAE used and the chamber tube air flow during the exposure period.
- Duration of treatment / exposure:
- 6 hours
- Frequency of treatment:
- on gestational days 6-15
- Dose / conc.:
- 0 ppm (nominal)
- Dose / conc.:
- 10 ppm (nominal)
- Dose / conc.:
- 30 ppm (nominal)
- Dose / conc.:
- 100 ppm (nominal)
- No. of animals per sex per dose:
- In a range-finding study, eight plug-positive females each were assigned to four DMEA-exposed groups (target DMEA concentrations 8, 25, 75 and 100 ppm) and an air-exposed control group.
In the definitive study, 25 plug-positive females each were assigned to three DMEA-exposed groups (10, 30 and 100 ppm) and a control group. - Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: Based on the results of the range-finding study.
The highest exposure concentration in the range-finding study, 100 ppm, was retained in the definitive study since it produced maternal toxicity (reduced body weights and weight gain, and clinical signs) and possible embryotoxicity (increased preimplantation loss) but no apparent fetotoxicity. The middle exposure concentration of 30 ppm chosen for the definitive study was slightly above the 25 ppm in the range-finding study which produced maternal toxicity (transient weight gain depression and clinical signs limited to the eyes) and possible embryotoxicity (reduced implantations, increased preimplantation loss and reduced number of viable fetuses per litter). The lowest exposure concentration, 10 ppm, was chosen as essentially the same as the 8 ppm in the range-finding study which produced no effects on maternal weights and only transient ocular changes and no evidence of embryofetal toxicity.
- Rationale for animal assignment (if not random): randomized - Positive control:
- no
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: Maternal body weights were measured on gd 0, 6, 12, 15, 18 and 21.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined: The gravid uterus, ovaries (including corpora lutea), cervix, vagina and peritoneal and thoracic cavities were examined grossly. Ovarian corpora lutea of pregnancy were counted. Maternal liver and uterine weights were measured. - Oestrous cyclicity (parental animals):
- no
- Sperm parameters (parental animals):
- no
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed ongestation day 21
- If yes, maximum of [..all ] pups/litter
PARAMETERS EXAMINED
The following parameters were examined in [F1 ] offspring: [number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities, other:]
GROSS EXAMINATION OF DEAD PUPS:
[no / yes, for external and internal abnormalities; possible cause of death was/was not determined for pups born or found dead.] - Postmortem examinations (parental animals):
- SACRIFICE
- Maternal animals: All surviving animals [on gd 21]
GROSS NECROPSY
- Gross necropsy consisted of [external and internal examinations including the cervical, thoracic, and abdominal viscera.]
HISTOPATHOLOGY /
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively.
OTHER:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: Uteri were examined externally for signs of hemorrhage. All live and dead fetuses were recorded - Postmortem examinations (offspring):
- - External examinations: Yes: [all per litter] including cleft palate
- Soft tissue examinations: Yes: [half per litter]
- Skeletal examinations: Yes: [half per litter]
- Head examinations: Yes: [half per litter] - Statistics:
- The unit of comparison was the pregnant female or the litter. Continuous quantitative data were compared between the DMEA-exposed groups and air-exposed control group by the use of Levene's test for equal variances analysis of variance (ANOVA) and t-tests with Bonferroni probabilities. The t-tests were used when the F value from the ANOVA was significant. When Levene's test indicated homogeneous variances, and the ANOVA was significant, the pooled t-test was used. When Levene's test indicated heterogeneous variances, all groups were compared by an ANOVA for unequal variances," followed by the separate variance t-test when necessary. Non-parametric data obtained following laparohysterectomy were statistically treated using the Kruskal- Wallis test followed by the Mann-Whitney U test when appropriate. Incidence data were compared using Fisher's exact test. For all statistical tests, the fiducial limit of 0.05 (two-tailed) was used as the criterion for significance.
- Reproductive indices:
- listed in the tables 1 and 3 in "Remarks on results"
- Offspring viability indices:
- listed in the table 3 in "Remarks on results"
- Clinical signs:
- effects observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- not examined
- Other effects:
- not examined
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- effects observed, treatment-related
- Dose descriptor:
- NOAEC
- Effect level:
- 10 ppm (nominal)
- Sex:
- female
- Basis for effect level:
- other: ocular effects, reduced body weight. In dams, no effects related to treatment.
- Clinical signs:
- effects observed, treatment-related
- Mortality / viability:
- mortality observed, treatment-related
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings:
- no effects observed
- Reproductive effects observed:
- not specified
- Conclusions:
- In summary, whole-body exposure to DMEA vapor of timed-pregnant Fischer 344 rats during organogenesis at 0, 10, 30 or 100 ppm resulted in maternal toxicity at 30 and 100 ppm (with transient minor ocular changes at 10 ppm). There was no evidence of embryonic or fetal toxicity, including teratogenicity, at any exposure concentration employed. Therefore, the no-observed-adverse-effect level is around 10 ppm for maternal toxicity and ≥ 100 ppm for embryofetal toxicity and teratogenicity in this study.
- Executive summary:
Timed-pregnant Fischer 344 rats were exposed whole body to N,N-dimethylethanolamine vapor for 6 h per day on gestational days 6-15 at mean (±SD) analytically measured concentrations of 10.4 ± 0.86, 29.8 ± 2.14 and 100 ± 4.9 ppm. Dams were sacrificed on gestational day 21. There was no maternal mortality in any exposed groups. Maternal toxicity observed in the 100 ppm group included reduced body weight during and after exposures, reduced weight gain during exposure and ocular changes (darkened, cloudy and hazy eyes, slight corneal vascularization and fixed, dilated pupils). Ocular effects were also noted in the other two exposure groups; the effects were quite marked at 30ppm but only minimal and transient at 10 ppm. There were no effects of treatment on any gestational parameters, including pre- and postimplantation loss or sex ratio. Fetal body weights per litter were statistically significantly increased at 100 ppm relative to controls. There were no increases in the incidences of total malformations by category (external, visceral or skeletal) or individually. The incidence of six skeletal variations out of 120 noted differed in exposed groups relative to that of control. Four of these variations were decreases in incidence; only one fetal variation, the split (bipartite) cervical centrum, was elevated at 100 ppm relative to controls. In the absence of any other indications of delayed ossification or fetal body weights, the observed fetal variation does not suggest a consistent pattern of fetal toxicity. Hence, the no-observed-adverse-effect level is around 10 ppm for maternal toxicity and at or above 100 ppm for embryofetal toxicity and teratogenicity.
Table 1. Pregnancy and litter data for Fischer 344 rats exposed whole body to N,N-dimethylethanolamine vapor |
||||
Exposure concentration (ppm) |
0 |
10 |
30 |
100 |
Number in study |
25 |
25 |
25 |
25 |
Number of early delivery |
1 |
0 |
0 |
0 |
Number aborted |
0 |
0 |
0 |
0 |
Number (%) pregnant at scheduled |
22 |
23 |
22 |
24 |
sacrifice |
(91.7) |
(92.0) |
(88.0) |
(96.0) |
Number of litters examined |
22 |
23 |
22 |
23a |
aOne dam carried a totally resorbed litter. |
Table 2. Maternal body weights and weight gains in Fischer 344 rats exposed whole body to N,N-dimethyIethanoIamine vapor |
|||||
Exposure conc. (ppm) |
0 |
10 |
30 |
100 |
|
Number of dams |
22 |
23 |
22 |
24 |
|
Maternal body weight3 |
|
|
|
|
|
gd 0 |
166.0 ± 8.1 |
165.0 ± 6.3 |
166.3 ± 7.6 |
166.6 ± 6.7 |
|
gd 6 |
178.1 ± 9.0 |
177.5 ± 5.9 |
178.8 ± 6.9 |
179.0 ± 7.4 |
|
gd 9 |
183.3 ± 9.9 |
181.8 ± 5.8 |
184.0 ± 6.7 |
179.8 ± 7.7 |
|
gd 12 |
193.1 ± 10.2 |
191.2 ± 6.0 |
193.4 ± 7.8 |
183.0 ± 8.2** |
|
gd 15 |
203.3 ± 10.8 |
200.0 ± 7.2 |
203.6 ± 8.9 |
187.4 ± 8.7*** |
|
gd 18 |
223.7 ± 12.5 |
218.1 ± 9.2 |
221.9 ± 11.4 |
207.9 ± 12.5*** |
|
gd 21 |
246.6 ± 15.6 |
238.2 ± 15.2 |
243.5 ± 17.6 |
233.1 ± 18.1* |
|
Body weight change3 |
|
|
|
|
|
gd 0-6 (pre-exposure) |
12.1 ± 4.6 |
12.5 ± 3.2 |
12.5 ± 3.5 |
12.4 ± 3.1 |
|
gd 6-9 |
5.2 ± 3.3 |
4.3 ± 1.9 |
5.2 ± 2.8 |
0.7 ± 2.5*** |
|
gd 6-12 |
15.0 ± 3.4 |
13.8 ± 2.4 |
14.6 ± 3.4 |
4.0 ± 5.1*** |
|
gd 6-15 (exposure) |
25.2 ± 5.1 |
22.6 ± 3.2 |
24.8 ± 5.3 |
8.4 ± 5.7*** |
|
gd 6-18 |
45.6 ± 7.4 |
40.6 ± 5.7 |
43.1 ± 9.3 |
28.9 ± 10.3*** |
|
gd 6-21 |
68.5 ± 9.9 |
60.7 ± 12.2 |
64.7 ± 16.2 |
54.1 ± 16.6** |
|
gd 15-21 (postexposure) |
43.3 ± 6.7 |
38.2 ± 9.9 |
39.9 ±11.9 |
45.7 ± 13.0 |
|
aln grams, mean ± SD. |
Table 3. Gestational parameters and fetal body weights in Fischer 344 rats exposed whole body toN,N-dimethylethanolamine vapor* |
||||
Exposure conc. (ppm) |
0 |
10 |
30 |
100 |
Number of dams |
22 |
23 |
22 |
24 |
Corpora lutea/dam |
11.4 ± 1.2 |
11.1 ± 1.2b |
11.3 ± 1.1 |
11.8 ± 1.2 |
Total implants/litter |
9.6 ± 1.7 |
7.9 ± 3.0 |
8.6 ± 3.3 |
8.5 ± 3.0 |
Preimplantation loss (%) |
15.5 ± 14.6 |
26.9 ± 25.4b |
25.9 ± 26.8 |
28.1 ± 24.3 |
Viable implants/litter |
9.5 ± 1.7 |
7.6 ± 3.1* |
8.5 ± 3.4 |
8.0 ± 3.3 |
Non-viable implants/litter |
0.0 ± 0.2 |
0.3 ± 0.6 |
0.1 ± 0.4 |
0.5 ± 1.5 |
Early resorptions |
0.0 ± 0.0 |
0.2 ± 0.5 |
0.0 ± 0.2 |
0.4 ± 1.4 |
Late resorptions |
0.0 ± 0.2 |
0.1 ± 0.3 |
0.1 ± 0.3 |
0.0 ± 0.0 |
Dead fetuses |
0.0 ± 0.0 |
0.0 ± 0.2 |
0.0 ± 0.0 |
0.0 ± 0.2 |
Live fetuses/litter (%/litter) |
99.5 ± 2.4 |
95.6 ± 9.0* |
97.9 ± 6.1 |
94.4 ± 20.6 |
Sex ratio (% males) |
56.0 ± 16.0 |
60.0 ± 21.0 |
41.6 ± 18.4* |
49.0 ± 16.9c |
Live litter size |
9.5 ± 1.7 |
7.6 ± 3.1* |
8.5 ± 3.4 |
8.4 ± 2.9c |
Fetal body weight/litter (g) |
|
|
|
|
All fetuses |
4.47 ± 0.15 |
4.56 ± 0.26 |
4.53 ± 0.24 |
4.66 ± 0.27c |
Male fetuses |
4.63 ± 0.16 |
4.67 ± 0.24 |
4.61 ± 0.26d |
4.82 ± 0.26*c |
Female fetuses |
4.28 ± 0.13 |
4.38 ± 0.26e |
4.43 ± 0.26 |
4.52 ± 0.30**c |
aValues presented as mean ± standard deviations; *p < 0.05 and **p < 0.01 versus control. |
Table 4. Skeletal variations in the fetuses of Fischer 344 rats exposed whole body toN,N-dimethylethanolamine vapor |
||||||||
|
Fetuses |
Litters |
||||||
Exposure concentration (ppm) |
0 |
10 |
30 |
100 |
0 |
10 |
30 |
100 |
Number examined skeletally |
102 |
82 |
89 |
91 |
22 |
23 |
20 |
23 |
Cervical centrum 6 poorly ossified |
43 |
46 |
48 |
33 |
22 |
21 |
18 |
15** |
Cervical centra 1, 2, 3 and/or 4 split |
3 |
2 |
6 |
13 |
3 |
2 |
5 |
12* |
Thoracic centrum 1 bilobed |
8 |
14 |
15 |
11 |
6 |
14* |
12 |
10 |
Thoracic centrum 9 bilobed |
14 |
5 |
6 |
6 |
12 |
5* |
6 |
6 |
Some proximal phalanges (forelimb) unossified |
7 |
0 |
5 |
5 |
6 |
0* |
5 |
5 |
Sternebra 5 bilobed |
16 |
10 |
6 |
14 |
12 |
5* |
5 |
11 |
*p < 0.05 and **p < 0.01 versus control. |
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 996
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- 2-dimethylaminoethanol
- EC Number:
- 203-542-8
- EC Name:
- 2-dimethylaminoethanol
- Cas Number:
- 108-01-0
- Molecular formula:
- C4H11NO
- IUPAC Name:
- 2-(dimethylamino)ethanol
- Details on test material:
- - Name of test material (as cited in study report): N,N-Dimethylethanolamine (DMEA) supplied by Union Carbide Corporation, South Charleston, WV.
- Substance type: organic
- Physical state: liquid
- Analytical purity: the test material remained at least 99.7% pure throughout the study
- Impurities (identity and concentrations): no
- Composition of test material, percentage of components: No significant compositional changes occurred
The purity and stability were verified before onset of exposures and after the exposures were completed.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague-Dawley, Inc., Indianapolis, IN.
- Age at study initiation: 67-79 days old on arrival
- Weight at study initiation: not reported
- Fasting period before study: no
- Housing: in stainless-steel wire-meshcages
- Diet (e.g. ad libitum): ad libitum except during exposure
- Water (e.g. ad libitum): ad libitum except during exposure
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not reported
- Humidity (%): not reported
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light):12/12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Liquid DMEA was metered from a piston pump into a heated glass maintained at the lowest temperature to vaporize the liquid. The resultant vapor was carried into the exposure chamber by a countercurrent flow of conditioned air through the evaporator. Exposure was conducted in 4320-litre stainless-steel and glass chambers at an airflow of 1000 L/min.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Chamber atmosphere was analyzed for DMEA concentrations once every 32 min during each 6-h exposure, using a Perkin-Elmer 3920B gas chromatograph equipped with a flame ionization detector. Nominal concentrations were calculated daily based on the amount of DMEA used and the chamber tube air flow during the exposure period.
- Details on mating procedure:
- - Impregnation procedure:[cohoused]
- If cohoused:
- M/F ratio per cage: 1/1
- Length of cohabitation: not reported
- Further matings after two unsuccessful attempts: [no]
- Verification of same strain and source of both sexes: [yes / no (explain)]
- Proof of pregnancy: [vaginal plug] referred to as [day 0] of pregnancy
- Any other deviations from standard protocol: - Duration of treatment / exposure:
- 6 h per day
- Frequency of treatment:
- each day
- Duration of test:
- on gestational days 6-15
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 ppm (nominal)
- Dose / conc.:
- 10 ppm (nominal)
- Dose / conc.:
- 30 ppm (nominal)
- Dose / conc.:
- 100 ppm (nominal)
- No. of animals per sex per dose:
- In a range-finding study, eight plug-positive females each were assigned to four DMEA-exposed groups (target DMEA concentrations 8, 25, 75 and 100 ppm) and an air-exposed control group.
In the definitive study, 25 plug-positive females each were assigned to three DMEA-exposed groups (10, 30 and 100 ppm) and a control group. - Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: Based on the results of the range-finding study.
The highest exposure concentration in the range-finding study, 100 ppm, was retained in the definitive study since it produced maternal toxicity (reduced body weights and weight gain, and clinical signs) and possible embryotoxicity (increased preimplantation loss) but no apparent fetotoxicity. The middle exposure concentration of 30 ppm chosen for the definitive study was slightly above the 25 ppm in the range-finding study which produced maternal toxicity (transient weight gain depression and clinical signs limited to the eyes) and possible embryotoxicity (reduced implantations, increased preimplantation loss and reduced number of viable fetuses per litter). The lowest exposure concentration, 10 ppm, was chosen as essentially the same as the 8 ppm in the range-finding study which produced no effects on maternal weights and only transient ocular changes and no evidence of embryofetal toxicity.
- Rationale for animal assignment (if not random): randomized
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes - Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes - Time schedule: daily
BODY WEIGHT: Yes - Time schedule for examinations:Maternal body weights were measured on gd 0, 6, 12, 15, 18 and 21.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21
- Organs examined: The gravid uterus, ovaries (including corpora lutea), cervix, vagina and peritoneal and thoracic cavities were examined grossly. Ovarian corpora lutea of pregnancy were counted. Maternal liver and uterine weights were measured. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: Uteri were examined externally for signs of hemorrhage. All live and dead fetuses were recorded- - Fetal examinations:
- - External examinations: Yes: [all per litter] including cleft palate
- Soft tissue examinations: Yes: [half per litter]
- Skeletal examinations: Yes: [half per litter]
- Head examinations: Yes: [half per litter] - Statistics:
- The unit of comparison was the pregnant female or the litter. Continuous quantitative data were compared between the DMEA-exposed groups and air-exposed control group by the use of Levene's test for equal variances analysis of variance (ANOVA) and t-tests with Bonferroni probabilities. The t-tests were used when the F value from the ANOVA was significant. When Levene's test indicated homogeneous variances, and the ANOVA was significant, the pooled t-test was used. When Levene's test indicated heterogeneous variances, all groups were compared by an ANOVA for unequal variances," followed by the separate variance t-test when necessary. Non-parametric data obtained following laparohysterectomy were statistically treated using the Kruskal- Wallis test followed by the Mann-Whitney U test when appropriate. Incidence data were compared using Fisher's exact test. For all statistical tests, the fiducial limit of 0.05 (two-tailed) was used as the criterion for significance.
- Indices:
- listed in the table 4 in "Remarks on results"
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Clinical examination showed that dams at 100 ppm only exhibited perinasal fur discoloration, presumably from chromodacryorrhea. At 30 and 100 ppm there were darkened (maroon), cloudy and hazy eyes, slight corneal vascularization and pupils dilated and fixed. Cloudy and hazy eyes were observed only during the exposure period. Darkened eyes were also observed at 10 ppm during the exposure period.
- Mortality:
- no mortality observed
- Description (incidence):
- There were no maternal deaths or abortions.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Reduced body weight and reduced body weight gain were observed at 100 ppm. Body weight reduced on gd 12 and 15 (during the exposure period) and on gd 15 and 21 (postexposure period). Body weight gain was reduced for all intervals except gd 6- 9 (pre-exposure) and gd 15-21 (post-exposure). There were no effects on body weight or body weight gain for the 10 or 30 ppm groups.
- Ophthalmological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- At 30 and 100 ppm there were darkened (maroon), cloudy and hazy eyes, slight corneal vascularization and pupils dilated and fixed. Cloudy and hazy eyes were observed only during the exposure period. Darkened eyes were also observed at 10 ppm during the exposure period.
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- There were no statistically significant differences in gravid uterine weight and absolute or relative liver weights between the DMEA-exposed groups and the controls.
- Description (incidence and severity):
- There were no effects of treatment on gonads.
Maternal developmental toxicity
- Number of abortions:
- no effects observed
- Description (incidence and severity):
- There were no maternal deaths or abortions.
- Pre- and post-implantation loss:
- no effects observed
- Description (incidence and severity):
- There were no effects of treatment on pre- and post implantation loss.
- Description (incidence and severity):
- Pregnancy rate ranged from 88 to 96% and all pregnant females had one or more live fetuses at scheduled sacrifice, except one dam at 100 ppm, which had a totally resorbed litter.
- Description (incidence and severity):
- Pregnancy rate ranged from 88 to 96% and all pregnant females had one or more live fetuses at scheduled sacrifice, except one dam at 100 ppm, which had a totally resorbed litter.
- Changes in pregnancy duration:
- no effects observed
- Description (incidence and severity):
- There were no effects of treatment on any gestational parameters.
- Changes in number of pregnant:
- no effects observed
- Description (incidence and severity):
- Pregnancy rate ranged from 88 to 96% and all pregnant females had one or more live fetuses at scheduled sacrifice, except one dam at 100 ppm, which had a totally resorbed litter.
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
Table 2 (in "Remarks on results") shows the pregnancy and litter data of all plug-positive females on study. There were no maternal deaths or abortions. Pregnancy rate ranged from 88 to 96% and all pregnant females had one or more live fetuses at scheduled sacrifice, except one dam at 100 ppm, which had a totally resorbed litter. Reduced body weight and reduced body weight gain were observed at 100 ppm. Body weight reduced on gd 12 and 15 (during the exposure period) and on gd 15 and 21 (postexposure period). Body weight gain was reduced for all intervals except gd 6- 9 (pre-exposure) and gd 15-2 1 (post-exposure). There were no effects on body weight or body weight gain for the 10 or 30 ppm groups. Clinical examination showed that dams at 100 ppm only exhibited perinasal fur discoloration, presumably from chromodacryorrhea. At 30 and 100 ppm there were darkened (maroon), cloudy and hazy eyes, slight corneal vascularization and pupils dilated and fixed. Cloudy and hazy eyes were observed only during the exposure period. Darkened eyes were also observed at 10ppm during the exposure period. There were no statistically significant differences in gravid uterine weight and absolute or relative liver weights between the DMEA-exposed groups and the controls.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 10 ppm (nominal)
- Basis for effect level:
- body weight and weight gain
- clinical signs
- ophthalmological examination
- other: maternal toxicity
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Description (incidence and severity):
- Fetal body weights were elevated at 100 ppm relative to those in controls.
- Reduction in number of live offspring:
- no effects observed
- Description (incidence and severity):
- The present developmental toxicity evaluation revealed no treatment-related embryotoxicity at any exposure concentration employed. No consistent pattern of fetotoxicity was observed.
- Changes in sex ratio:
- no effects observed
- Description (incidence and severity):
- The present developmental toxicity evaluation revealed no treatment-related embryotoxicity at any exposure concentration employed. No consistent pattern of fetotoxicity was observed. There were no effects of treatment on sex ratio.
- Changes in litter size and weights:
- no effects observed
- Description (incidence and severity):
- The present developmental toxicity evaluation revealed no treatment-related embryotoxicity at any exposure concentration employed. No consistent pattern of fetotoxicity was observed.
- Changes in postnatal survival:
- no effects observed
- Description (incidence and severity):
- The present developmental toxicity evaluation revealed no treatment-related embryotoxicity at any exposure concentration employed. No consistent pattern of fetotoxicity was observed.
- External malformations:
- no effects observed
- Description (incidence and severity):
- No increases in malformations were observed at any concentration of DMEA employed, including those which produced maternal toxicity.
- Skeletal malformations:
- no effects observed
- Description (incidence and severity):
- One skeletal district, the cervical centra, exhibited evidence of reduced ossification at 100 ppm, an exposure concentration which also produced maternal toxicity. This finding is the only one which could be consistent with indicating possible minimal fetotoxicity; however, there were no other indications of fetotoxicity, such as reduced fetal body weight. No other skeletal districts, of the number identified as sensitive indicators of delayed development in rat fetuses,” exhibited a delay in ossification. No increases in malformations were observed at any concentration of DMEA employed, including those which produced maternal toxicity.
- Visceral malformations:
- no effects observed
- Description (incidence and severity):
- No increases in malformations were observed at any concentration of DMEA employed, including those which produced maternal toxicity.
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
The present developmental toxicity evaluation revealed no treatment-related embryotoxicity at any exposure concentration employed. No consistent pattern of fetotoxicity was observed. Fetal body weights were elevated at 100 ppm relative to those in controls (Table 3), and only one skeletal district, the cervical centra, exhibited evidence of reduced ossification at 100 ppm (Table 4), an exposure concentration which also produced maternal toxicity. This finding is the only one which could be consistent with indicating possible minimal fetotoxicity; however, there were no other indications of fetotoxicity, such as reduced fetal body weight. No other skeletal districts, of the number identified as sensitive indicators of delayed development in rat fetuses,” exhibited a delay in ossification. No increases in malformations were observed at any concentration of DMEA employed, including those which produced maternal toxicity.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- >= 100 ppm (nominal)
- Basis for effect level:
- other: see "Remarks"
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Table 2. Pregnancy and litter data for Fischer 344 rats exposed whole body to N,N-dimethylethanolamine vapor |
||||
Exposure concentration (ppm) |
0 |
10 |
30 |
100 |
Number in study |
25 |
25 |
25 |
25 |
Number of early delivery |
1 |
0 |
0 |
0 |
Number aborted |
0 |
0 |
0 |
0 |
Number (%) pregnant at scheduled |
22 |
23 |
22 |
24 |
sacrifice |
(91.7) |
(92.0) |
(88.0) |
(96.0) |
Number of litters examined |
22 |
23 |
22 |
23a |
aOne dam carried a totally resorbed litter. |
Table 3. Gestational parameters and fetal body weights in Fischer 344 rats exposed whole body to N,N-dimethylethanolamine vapor* |
||||
Exposure conc. (ppm) |
0 |
10 |
30 |
100 |
Number of dams |
22 |
23 |
22 |
24 |
Corpora lutea/dam |
11.4 ± 1.2 |
11.1 ± 1.2b |
11.3 ± 1.1 |
11.8 ± 1.2 |
Total implants/litter |
9.6 ± 1.7 |
7.9 ± 3.0 |
8.6 ± 3.3 |
8.5 ± 3.0 |
Preimplantation loss (%) |
15.5 ± 14.6 |
26.9 ± 25.4b |
25.9 ± 26.8 |
28.1 ± 24.3 |
Viable implants/litter |
9.5 ± 1.7 |
7.6 ± 3.1* |
8.5 ± 3.4 |
8.0 ± 3.3 |
Non-viable implants/litter |
0.0 ± 0.2 |
0.3 ± 0.6 |
0.1 ± 0.4 |
0.5 ± 1.5 |
Early resorptions |
0.0 ± 0.0 |
0.2 ± 0.5 |
0.0 ± 0.2 |
0.4 ± 1.4 |
Late resorptions |
0.0 ± 0.2 |
0.1 ± 0.3 |
0.1 ± 0.3 |
0.0 ± 0.0 |
Dead fetuses |
0.0 ± 0.0 |
0.0 ± 0.2 |
0.0 ± 0.0 |
0.0 ± 0.2 |
Live fetuses/litter (%/litter) |
99.5 ± 2.4 |
95.6 ± 9.0* |
97.9 ± 6.1 |
94.4 ± 20.6 |
Sex ratio (% males) |
56.0 ± 16.0 |
60.0 ± 21.0 |
41.6 ± 18.4* |
49.0 ± 16.9c |
Live litter size |
9.5 ± 1.7 |
7.6 ± 3.1* |
8.5 ± 3.4 |
8.4 ± 2.9c |
Fetal body weight/litter (g) |
|
|
|
|
All fetuses |
4.47 ± 0.15 |
4.56 ± 0.26 |
4.53 ± 0.24 |
4.66 ± 0.27c |
Male fetuses |
4.63 ± 0.16 |
4.67 ± 0.24 |
4.61 ± 0.26d |
4.82 ± 0.26*c |
Female fetuses |
4.28 ± 0.13 |
4.38 ± 0.26e |
4.43 ± 0.26 |
4.52 ± 0.30**c |
aValues presented as mean ± standard deviations; *p < 0.05 and **p < 0.01 versus control. |
Table 4. Skeletal variations in the fetuses of Fischer 344 rats exposed whole body to N,N-dimethylethanolamine vapor |
||||||||
|
Fetuses |
Litters |
||||||
Exposure concentration (ppm) |
0 |
10 |
30 |
100 |
0 |
10 |
30 |
100 |
Number examined skeletally |
102 |
82 |
89 |
91 |
22 |
23 |
20 |
23 |
Cervical centrum 6 poorly ossified |
43 |
46 |
48 |
33 |
22 |
21 |
18 |
15** |
Cervical centra 1, 2, 3 and/or 4 split |
3 |
2 |
6 |
13 |
3 |
2 |
5 |
12* |
Thoracic centrum 1 bilobed |
8 |
14 |
15 |
11 |
6 |
14* |
12 |
10 |
Thoracic centrum 9 bilobed |
14 |
5 |
6 |
6 |
12 |
5* |
6 |
6 |
Some proximal phalanges (forelimb) unossified |
7 |
0 |
5 |
5 |
6 |
0* |
5 |
5 |
Sternebra 5 bilobed |
16 |
10 |
6 |
14 |
12 |
5* |
5 |
11 |
*p < 0.05 and **p < 0.01 versus control. |
Applicant's summary and conclusion
- Conclusions:
- In summary, whole-body exposure to DMEA vapor of timed-pregnant Fischer 344 rats during organogenesis at 0, 10, 30 or 100 ppm resulted in maternal toxicity at 30 and 100 ppm (with transient minor ocular changes at 10 ppm). There was no evidence of embryonic or fetal toxicity, including teratogenicity, at any exposure concentration employed. Therefore, the no-observed-adverse-effect level (NOAEL) is around 10 ppm for maternal toxicity and ≥ 100 ppm for embryofetal toxicity and teratogenicity in this study.
- Executive summary:
Timed-pregnant Fischer 344 rats were exposed whole body to N,N-dimethylethanolamine vapor for 6 h per day on gestational days 6-15 at mean (± SD) analytically measured concentrations of 10.4 ± 0.86, 29.8 ± 2.14 and 100 ± 4.9 ppm. Dams were sacrificed on gestational day 21. There was no maternal mortality in any exposed groups. Maternal toxicity observed in the 100 ppm group included reduced body weight during and after exposures, reduced weight gain during exposure and ocular changes (darkened, cloudy and hazy eyes, slight corneal vascularization and fixed, dilated pupils). Ocular effects were also noted in the other two exposure groups; the effects were quite marked at 30 ppm but only minimal and transient at 10 ppm. There were no effects of treatment on any gestational parameters, including pre- and postimplantation loss or sex ratio. Fetal body weights per litter were statistically significantly increased at 100 ppm relative to controls. There were no increases in the incidences of total malformations by category (external, visceral or skeletal) or individually. The incidence of six skeletal variations out of 120 noted differed in exposed groups relative to that of control. Four of these variations were decreases in incidence; only one fetal variation, the split (bipartite) cervical centrum, was elevated at 100 ppm relative to controls. In the absence of any other indications of delayed ossification or fetal body weights, the observed fetal variation does not suggest a consistent pattern of fetal toxicity. Hence, the no-observed-adverse-effect level (NOAEL) is around 10 ppm for maternal toxicity and at or above 100 ppm for embryofetal toxicity and teratogenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
